Insulin detemir - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
LEVEMIR FLEXPEN insulin detemir (rys) 100 U/mL injection cartridge
AUST R: 172234
Active ingredients:
Insulin detemir

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800 668 626

Deletion from market:
31 Dec 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
The TGA is investigating management strategies and will consult with subject matter experts and sponsors. The sponsor will continue to supply until the market deletion date.
LEVEMIR PENFILL insulin detemir (rys) 100 U/mL injection cartridge
AUST R: 172213
Active ingredients:
Insulin detemir

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800 668 626

Deletion from market:
31 Dec 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
The TGA is investigating management strategies and will consult with subject matter experts and sponsors. The sponsor will continue to supply until the market deletion date.